Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream... Show more
OCPNF saw its Momentum Indicator move above the 0 level on November 10, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned positive. In of the 68 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for OCPNF just turned positive on November 10, 2025. Looking at past instances where OCPNF's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
OCPNF moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
OCPNF broke above its upper Bollinger Band on November 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCPNF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.265) is normal, around the industry mean (63.027). P/E Ratio (25.083) is within average values for comparable stocks, (35.851). OCPNF's Projected Growth (PEG Ratio) (4.272) is slightly higher than the industry average of (1.651). Dividend Yield (0.010) settles around the average of (0.019) among similar stocks. P/S Ratio (2.508) is also within normal values, averaging (60.827).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCPNF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QQQD | 13.75 | 0.24 | +1.78% |
| Direxion Daily Concentrated Qs Bear 1X Shares | |||
| VFLO | 37.60 | 0.10 | +0.27% |
| VictoryShares Free Cash Flow ETF | |||
| SDSI | 51.59 | 0.05 | +0.10% |
| American Century® Short Dur Str Inc ETF | |||
| IBMQ | 25.52 | 0.01 | +0.06% |
| iShares iBonds Dec 2028 Term Muni Bd ETF | |||
| MYMJ | 24.85 | N/A | +0.02% |
| SPDR SSGA My2030 Municipal Bond ETF | |||
A.I.dvisor indicates that over the last year, OCPNF has been loosely correlated with OLYMY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OCPNF jumps, then OLYMY could also see price increases.
| Ticker / NAME | Correlation To OCPNF | 1D Price Change % | ||
|---|---|---|---|---|
| OCPNF | 100% | N/A | ||
| OLYMY - OCPNF | 40% Loosely correlated | -1.14% | ||
| POCI - OCPNF | 1% Poorly correlated | +4.39% | ||
| NVYTF - OCPNF | 1% Poorly correlated | N/A | ||
| PFGTF - OCPNF | -0% Poorly correlated | N/A | ||
| OSSUY - OCPNF | -2% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To OCPNF | 1D Price Change % |
|---|---|---|
| OCPNF | 100% | N/A |
| Medical/Nursing Services industry (216 stocks) | 8% Poorly correlated | +0.36% |
| Health Services industry (423 stocks) | -0% Poorly correlated | +0.16% |